Related Experiment Video
Updated: Jul 16, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression
S J Clark1, S Creighton, M Horner
1Department of Liver Studies, King's College Hospital, Denmark Hill, London, UK. Sarah.Clark@stgeorges.nhs.uk
Abstract:
The effect of HIV-related immunosuppression and antiretroviral therapy on the reactivation of latent hepatitis B virus (HBV) infection is unclear. We report four patients with advanced HIV-related immunosuppression and abnormal liver function tests who had evidence of HBV reactivation. Reclearance of hepatitis B occurred in two cases with HIV treatment regimens not containing lamivudine, suggesting that improved immune function may be responsible. In three cases, HBV reactivation was recognized during investigation for abnormal liver function initially attributed to drug toxicity. The possibility of HBV reactivation must be considered in the differential diagnosis of abnormal liver function in cases with advanced HIV.
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Size and Structure of Viral Genomes
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

